Publication Information

{'id': 'https://openalex.org/W2087964934', 'doi': 'https://doi.org/10.1158/1535-7163.pms-b13', 'title': 'Abstract B13: ATR and PARP inhibition enhances topoisomerase I-dependent DNA damage in colon cancer cell lines', 'display_name': 'Abstract B13: ATR and PARP inhibition enhances topoisomerase I-dependent DNA damage in colon cancer cell lines', 'publication_year': 2013, 'publication_date': '2013-05-01', 'ids': {'openalex': 'https://openalex.org/W2087964934', 'doi': 'https://doi.org/10.1158/1535-7163.pms-b13', 'mag': '2087964934'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.pms-b13', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5054275696', 'display_name': 'Atlal Abusanad', 'orcid': 'https://orcid.org/0000-0002-0790-9861'}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Atlal Abu-Sanad', 'raw_affiliation_strings': ['#N# 1McGill University, Montreal, QC, Canada'], 'affiliations': [{'raw_affiliation_string': '#N# 1McGill University, Montreal, QC, Canada', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042063888', 'display_name': 'David Davidson', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'David Davidson', 'raw_affiliation_strings': ['#N# 1McGill University, Montreal, QC, Canada'], 'affiliations': [{'raw_affiliation_string': '#N# 1McGill University, Montreal, QC, Canada', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039740503', 'display_name': 'Yunzhe Wang', 'orcid': 'https://orcid.org/0000-0003-0599-6989'}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Yunzhe Wang', 'raw_affiliation_strings': ['#N# 1McGill University, Montreal, QC, Canada'], 'affiliations': [{'raw_affiliation_string': '#N# 1McGill University, Montreal, QC, Canada', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085072340', 'display_name': 'John R. Pollard', 'orcid': 'https://orcid.org/0009-0001-7995-9606'}, 'institutions': [{'id': 'https://openalex.org/I4210127480', 'display_name': 'Vertex Pharmaceuticals (United Kingdom)', 'ror': 'https://ror.org/03fs5jd74', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I4210127480', 'https://openalex.org/I61970326']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'John Pollard', 'raw_affiliation_strings': ['2Vertex Pharmaceuticals, Abingdon, Oxfordshire, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '2Vertex Pharmaceuticals, Abingdon, Oxfordshire, United Kingdom.', 'institution_ids': ['https://openalex.org/I4210127480']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005764534', 'display_name': 'Raquel Aloyz', 'orcid': 'https://orcid.org/0000-0002-6812-497X'}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Raquel Aloyz', 'raw_affiliation_strings': ['#N# 1McGill University, Montreal, QC, Canada'], 'affiliations': [{'raw_affiliation_string': '#N# 1McGill University, Montreal, QC, Canada', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5049481562', 'display_name': 'Lawrence Panasci', 'orcid': 'https://orcid.org/0000-0002-5141-5594'}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Lawrence Panasci', 'raw_affiliation_strings': ['#N# 1McGill University, Montreal, QC, Canada'], 'affiliations': [{'raw_affiliation_string': '#N# 1McGill University, Montreal, QC, Canada', 'institution_ids': ['https://openalex.org/I5023651']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '12', 'issue': '5_Supplement', 'first_page': 'B13', 'last_page': 'B13'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10123', 'display_name': 'DNA Repair Mechanisms', 'score': 0.9916, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9909, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/parp-inhibitor', 'display_name': 'PARP inhibitor', 'score': 0.61506164}, {'id': 'https://openalex.org/keywords/ic50', 'display_name': 'IC50', 'score': 0.4809279}, {'id': 'https://openalex.org/keywords/synthetic-lethality', 'display_name': 'Synthetic Lethality', 'score': 0.43109718}], 'concepts': [{'id': 'https://openalex.org/C109316439', 'wikidata': 'https://www.wikidata.org/wiki/Q246181', 'display_name': 'Cytotoxicity', 'level': 3, 'score': 0.7324618}, {'id': 'https://openalex.org/C2779012473', 'wikidata': 'https://www.wikidata.org/wiki/Q3235015', 'display_name': 'RAD51', 'level': 4, 'score': 0.6329404}, {'id': 'https://openalex.org/C143425029', 'wikidata': 'https://www.wikidata.org/wiki/Q5205747', 'display_name': 'DNA damage', 'level': 3, 'score': 0.625858}, {'id': 'https://openalex.org/C2779138821', 'wikidata': 'https://www.wikidata.org/wiki/Q7118227', 'display_name': 'PARP inhibitor', 'level': 5, 'score': 0.61506164}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.5861944}, {'id': 'https://openalex.org/C134935766', 'wikidata': 'https://www.wikidata.org/wiki/Q210538', 'display_name': 'DNA repair', 'level': 3, 'score': 0.58053994}, {'id': 'https://openalex.org/C96232424', 'wikidata': 'https://www.wikidata.org/wiki/Q4118072', 'display_name': 'Cancer cell', 'level': 3, 'score': 0.49536216}, {'id': 'https://openalex.org/C147897179', 'wikidata': 'https://www.wikidata.org/wiki/Q407828', 'display_name': 'Topoisomerase', 'level': 3, 'score': 0.49415997}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.48743203}, {'id': 'https://openalex.org/C2777752497', 'wikidata': 'https://www.wikidata.org/wiki/Q286779', 'display_name': 'IC50', 'level': 3, 'score': 0.4809279}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.46483254}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.4451147}, {'id': 'https://openalex.org/C2778502085', 'wikidata': 'https://www.wikidata.org/wiki/Q7662767', 'display_name': 'Synthetic lethality', 'level': 4, 'score': 0.43109718}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.4204267}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.3953553}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.3949414}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.34441137}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.32575595}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.29075444}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.16943151}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.08694044}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.pms-b13', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.83}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4236143807', 'https://openalex.org/W4229451438', 'https://openalex.org/W2808928250', 'https://openalex.org/W2808701886', 'https://openalex.org/W2740076773', 'https://openalex.org/W2604684522', 'https://openalex.org/W2548423821', 'https://openalex.org/W2145392202', 'https://openalex.org/W2101012300', 'https://openalex.org/W1645329610'], 'abstract_inverted_index': {'Abstract': [0], 'Introduction:': [1], 'The': [2, 144, 351], 'understanding': [3], 'of': [4, 15, 26, 39, 58, 65, 73, 154, 189, 203, 214, 233, 266, 316, 340, 346, 417], 'DNA': [5, 27, 46, 161, 367, 407], 'repairs': [6], 'pathways': [7, 48], 'and': [8, 124, 158, 174, 247, 277, 283, 292, 369, 401], 'their': [9], 'interactions': [10], 'allowed': [11], 'for': [12], 'the': [13, 24, 37, 66, 71, 132, 137, 152, 201, 206, 212, 218, 231, 254, 260, 264, 290, 299, 304, 309, 314, 321, 327, 418], 'development': [14], 'several': [16, 40], 'targeted': [17], 'therapies,': [18], 'which': [19], 'sensitize': [20], 'neoplastic': [21], 'cells': [22, 100, 105, 333], 'to': [23, 90, 103, 150, 196, 227, 238, 244, 250, 274, 332, 383, 426], 'effects': [25], 'damaging': [28], 'chemotherapy.': [29, 385], 'Poly-ADP': [30], 'ribose': [31], 'polymerase': [32], '(PARP)': [33], 'inhibitors': [34, 216], 'can': [35], 'increase': [36], 'cytotoxicity': [38, 146], 'anticancer': [41], 'agents': [42, 75, 93, 166], 'by': [43, 164, 169, 313], 'inhibiting': [44], 'various': [45, 91], 'repair': [47, 54], 'including': [49], 'Rad51': [50], 'related': [51], 'homologous': [52], 'recombinational': [53], '(HRR).': [55], 'However,': [56], 'inhibition': [57, 403], 'PARP': [59, 78, 133, 402], 'may': [60, 377], 'result': [61], 'in': [62, 98, 159, 200, 205, 223, 230, 289, 303, 355, 358, 409], 'compensatory': [63], 'activation': [64], 'ATR': [67, 83, 138, 400], 'pathway': [68], 'partially': [69], 'limiting': [70], 'sensitization': [72, 89], 'chemotherapeutic': [74, 92], 'seen': [76, 286], 'with': [77, 94, 130, 287, 326, 335, 343, 365], 'inhibitors.': [79], 'Recently,': [80], 'a': [81, 194, 224], 'specific': [82], 'inhibitor,': [84], 'VE-821': [85, 192], 'has': [86], 'demonstrated': [87, 193], 'excellent': [88], 'preferential': [95], 'antitumor': [96], 'activity': [97], 'tumor': [99], 'as': [101, 330], 'compared': [102, 273, 331], 'normal': [104], '(Reaper': [106], 'PM': [107], 'et': [108], 'al': [109], 'Nature': [110], 'Chem': [111], 'Biol': [112], '7:': [113], '428-30,': [114], '2011)': [115], 'Colon': [116], 'cancer': [117, 208, 361, 381, 411], 'cell': [118, 209, 262, 270, 294, 306, 311, 323, 362, 412], 'lines:': [119], 'HCT116/Lovo': [120], '(p53': [121, 126], 'wild': [122], 'type)': [123], 'HT29': [125, 241], 'mutated)': [127], 'were': [128, 179, 285], 'treated': [129, 325, 334], 'SN38,': [131], 'inhibitor': [134, 139], '(ABT-888)': [135], 'and/or': [136], '(VE821)': [140], 'at': [141, 217], 'different': [142], 'concentrations.': [143], 'SRB': [145], 'assay': [147, 302], 'was': [148, 167, 257, 348], 'used': [149], 'determine': [151], 'IC50': [153, 202, 232], 'each': [155], 'drug': [156, 182], 'separately': [157], 'combination.': [160], 'damage': [162, 368, 408], 'caused': [163], 'these': [165], 'quantified': [168], 'phosphorylated-H2AX.': [170], 'Cell': [171], 'cycle': [172, 271], 'alterations': [173], 'protein': [175], 'levels': [176], '(western': [177], 'analysis)': [178], 'determined': [180], 'after': [181], 'treatment.': [183], 'Results:': [184], 'Nontoxic': [185], 'concentrations': [186, 221], '(0.5-1': [187], 'μM)': [188], 'ABT-888': [190], 'or': [191], 'two': [195], 'three': [197, 318], 'fold': [198], 'decrease': [199, 229], 'SN38': [204, 234, 278, 336], 'colon': [207, 360, 380, 410], 'lines.': [210, 295, 413], 'Significantly,': [211], 'combination': [213, 265, 315, 329, 353, 376], 'both': [215], 'same': [219], 'nontoxic': [220], 'resulted': [222, 354], 'dramatic': [225], '4': [226], '25-fold': [228], '[HCT116': [235], '(8.1': [236], 'nM': [237, 243], '0.3': [239], 'nM),': [240], '(20.5': [242], '3.9': [245], 'nM)': [246], 'Lovo': [248, 261, 291], '(13.5nM': [249], '3': [251], 'nM)].': [252], 'Notably,': [253], 'observed': [255], 'effect': [256], 'dose-dependent.': [258], 'In': [259, 320], 'line,': [263, 324], 'SN38/VE821/ABT888': [267, 288, 328], 'increased': [268, 281, 310, 338, 366], 'G2/M': [269], 'arrest': [272], 'SN38/VE821,': [275], 'SN38/ABT888': [276], 'alone.': [279], 'Similarly,': [280], 'phosphorylated-H2AX': [282], 'apoptosis': [284, 301], 'HCT-116': [293], 'Preliminary': [296], 'data': [297, 372], 'utilizing': [298], 'annexin-5': [300], 'HCT116': [305, 322], 'line': [307], 'supports': [308], 'killing': [312], 'all': [317, 359], 'agents.': [319], 'alone,': [337], 'expression': [339, 345], 'p21': [341], 'along': [342], 'decreased': [344], 'phospho-Chk1': [347], 'observed.': [349], 'Conclusion:': [350], 'SN38/ABT888/VE821': [352], 'maximal': [356], 'synergy/chemosensitivity': [357], 'lines,': [363], 'associated': [364], 'apoptosis.': [370], 'Our': [371], 'suggests': [373], 'that': [374], 'this': [375], 'effectively': [378], 'overcome': [379], 'resistance': [382], 'irinotecan-based': [384], 'Citation': [386], 'Format:': [387], 'Atlal': [388], 'Abu-Sanad,': [389], 'David': [390], 'Davidson,': [391], 'Yunzhe': [392], 'Wang,': [393], 'John': [394], 'Pollard,': [395], 'Raquel': [396], 'Aloyz,': [397], 'Lawrence': [398], 'Panasci.': [399], 'enhances': [404], 'topoisomerase': [405], 'I-dependent': [406], '[abstract].': [414], 'In:': [415], 'Proceedings': [416], 'AACR': [419], 'Precision': [420], 'Medicine': [421], 'Series:': [422], 'Synthetic': [423], 'Lethal': [424], 'Approaches': [425], 'Cancer': [427, 438], 'Vulnerabilities;': [428], 'May': [429], '17-20,': [430], '2013;': [431], 'Bellevue,': [432], 'WA.': [433], 'Philadelphia': [434], '(PA):': [435], 'AACR;': [436], 'Mol': [437], 'Ther': [439], '2013;12(5': [440], 'Suppl):Abstract': [441], 'nr': [442], 'B13.': [443]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2087964934', 'counts_by_year': [], 'updated_date': '2024-12-08T12:46:50.568636', 'created_date': '2016-06-24'}